Several portfolio companies, including Evolent, Prodigo, and Vivify Health were featured in the news in the past month.
February featured a unicorn sighting in Health Catalyst, a new partnership announcement from RxAnte, and the launch of Vivify’s next generation mobile solution. Find out what other portfolio companies were in the news below.
Health care providers have begun to pay closer attention to the importance of social determinants but continue to struggle with effective ways to monitor and track factors. Anita Cattrell of Evolent Health was recently quoted in a Modern Healthcare story on how software is helping to make that a reality.
Health Catalyst’s latest round of funding officially put the company above the $1 billion mark, moving it into the rarefied air known as unicorn status. Hear from CEO, Dan Burton on what this means for the company and what to expect from Health Catalyst moving forward.
In the final installment of Prodigo’s sponsored content series with Spend Matters, the publication looks into the value of data, specifically, data standards challenges and how the industry can integrate clinical data into its supply chain.
RxAnte is partnering with Pennsylvania-based health insurer, Geisinger Health Plan. The partnership is designed to deliver population-level analysis and member-level decision support to inform Geisinger’s pharmacy quality strategy. Specifically, the program will focus on driving adherence to medications related to diabetes, hypertension, and high cholesterol.
Vivify Health is extending on its existing Bring Your Own Device (BYOD) mobile app with the launch of Pathways +Go. This app “takes a significant leap forward in the industry with the addition of intelligent logic to customize clinical algorithms from real-time and historic patient data.” It includes a host of features ranging from real-time notifications and secure messaging to ad hoc multi-person virtual visits.
